MLchartDataset catalogue

immunoconjugate therapy

Term · Oncology and biomedicine · MLC-T-ONC-004218

A type of treatment that uses an immune substance, such as a monoclonal antibody, that is chemically linked to a cell-killing substance such as a toxin, radioisotope, or drug. The immune substance targets certain types of cells and the linked substance kills the targeted cells without harming other cells. Immunoconjugates are used in the treatment of cancer. Examples include antibody-drug conjugates, immunotoxins, and some targeted therapy drugs.

Table 1. Record
IdentifierMLC-T-ONC-004218
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-004218",
  "term": "immunoconjugate therapy",
  "field": "Oncology and biomedicine",
  "definition": "A type of treatment that uses an immune substance, such as a monoclonal antibody, that is chemically linked to a cell-killing substance such as a toxin, radioisotope, or drug. The immune substance targets certain types of cells and the linked substance kills the targeted cells without harming other cells. Immunoconjugates are used in the treatment of cancer. Examples include antibody-drug conjugates, immunotoxins, and some targeted therapy drugs.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/immunoconjugate-therapy/"
}

Record 9,092 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.